SCHEMBL11938229

SCHEMBL11938229

O=C(NCCOCCO)C(F)(F)OC(F)(F)C(F)(F)OC(F)(F)C(=O)NCCOCCO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.41
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ MEN1 O00255 4/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ ATG4B Q9Y4P1 1/20 0.32
▸ CA3 P07451 2/20 0.32
▸ CA5A P35218 2/20 0.32
▸ CA5B Q9Y2D0 2/20 0.32
▸ CA12 O43570 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA4 P22748 1/20 0.32
▸ CA6 P23280 1/20 0.32
▸ CA7 P43166 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ CA14 Q9ULX7 1/20 0.32
▸ KCNH3 Q9ULD8 1/20 0.31
▸ EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11938254 0.92 ALDH1A1 (0.36) ALDH1A1TSHRMAPK1SMN1; SMN2POLB
SCHEMBL13915151 0.84 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL13915083 0.84 MEN1 (0.37) ALDH1A1TSHRMAPK1SMN1; SMN2POLB
SCHEMBL2777997 0.83 ALDH1A1 (0.54) ALDH1A1TSHRMAPK1SMN1; SMN2POLB
SCHEMBL24243983 0.81 SMN1; SMN2 (0.52) ALDH1A1TSHRMAPK1SMN1; SMN2POLB
SCHEMBL15062363 0.81 SMN1; SMN2 (0.52) ALDH1A1TSHRMAPK1SMN1; SMN2POLB
SCHEMBL3230281 0.81 SMN1; SMN2 (0.52) ALDH1A1TSHRMAPK1SMN1; SMN2POLB
SCHEMBL3219761 0.81 SMN1; SMN2 (0.52) ALDH1A1TSHRMAPK1SMN1; SMN2POLB
SCHEMBL14980570 0.81 MEN1 (0.39) ALDH1A1TSHRSMN1; SMN2POLBMEN1
SCHEMBL13915152 0.78 PAOX (0.38) ALDH1A1TSHRMAPK1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8227610-B2 Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques CARNEGIE MELLON UNIVERSITY (US) 2012-07-24 — — US disclosed
US-20090074673-A1 Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques CARNEGIE MELLON UNIVERSITY (US) 2009-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090074673-A1 Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques NES, MKI67, CD68 ALDH1A1 4063/4885TSHR 3981/4885MAPK1 2374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback